Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer
Cellular & Molecular Immunology - Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer